​

Krystal Biotech (KRYS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Krystal Biotech Revenue Highlights

Latest Revenue (Y)

$290.51M

Latest Revenue (Q)

$91.14M

Krystal Biotech Revenue by Period

Krystal Biotech Revenue by Year

DateRevenueChange
2024-12-31$290.51M473.02%
2023-12-31$50.70M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$1.03M100.00%
2017-12-31-100.00%
2016-12-31--

Krystal Biotech generated $290.51M in revenue during NA 2024, up 473.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Krystal Biotech Revenue by Quarter

DateRevenueChange
2024-12-31$91.14M8.70%
2024-09-30$83.84M19.29%
2024-06-30$70.28M55.32%
2024-03-31$45.25M7.37%
2023-12-31$42.14M392.55%
2023-09-30$8.56M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$542.00K-7.03%
2019-03-31$583.00K-43.23%
2018-12-31$1.03M373.27%
2018-09-30$217.00K25.43%
2018-06-30$173.00K36.22%
2018-03-31$127.00K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Krystal Biotech generated $91.14M in revenue during Q4 2024, up 8.70% compared to the previous quarter, and up 1065.21% compared to the same period a year ago.

Krystal Biotech Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTCTPTC Therapeutics$806.78M$213.17M
APLSApellis Pharmaceuticals$709.95M$212.53M
BPMCBlueprint Medicines$508.82M$149.41M
KRYSKrystal Biotech$290.51M$91.14M
RYTMRhythm Pharmaceuticals$130.13M$41.83M
RGNXREGENXBIO$83.33M$89.01M
MRUSMerus$36.13M$9.14M
MGTXMeiraGTx$33.28M-
RCKTRocket Pharmaceuticals--

KRYS Revenue FAQ

What is Krystal Biotech’s yearly revenue?

Krystal Biotech's yearly revenue for 2024 was $290.52M, representing an increase of 473.02% compared to 2023. The company's yearly revenue for 2023 was $50.7M, representing an increase of 100.00% compared to 2022. KRYS's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Krystal Biotech’s quarterly revenue?

Krystal Biotech's quarterly revenue for Q4 2024 was $91.14M, a 8.70% increase from the previous quarter (Q3 2024), and a 116.26% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $83.84M, a 19.29% increase from the previous quarter (Q2 2024), and a 879.91% increase year-over-year (Q3 2023). KRYS's quarterly revenue for Q2 2024 was $70.28M, a 55.32% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Krystal Biotech’s revenue growth rate?

Krystal Biotech's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.